/
More on Generic Drugs More on Generic Drugs

More on Generic Drugs - PowerPoint Presentation

lindy-dunigan
lindy-dunigan . @lindy-dunigan
Follow
389 views
Uploaded On 2017-12-13

More on Generic Drugs - PPT Presentation

Global Classrooms 2013 Rachel Hunkler Noncommunicable diseases Also known as chronic diseases They are not contagious Ex cancer diabetes Alzheimers MS arthritis heart disease noncommunicable diseaseaccounts for more than 60 percent of deaths globally 80 in the de ID: 614973

drugs generic drug patent generic drugs patent drug global companies nations classrooms diseases pharma world communicable medical tiered compulsory

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "More on Generic Drugs" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

More on Generic Drugs

Global Classrooms 2013Rachel HunklerSlide2

Non-communicable diseases

Also known as “chronic diseases”They are not contagious!

Ex: cancer, diabetes, Alzheimer's, MS, arthritis, heart disease

“…non-communicable disease…accounts for more than 60 percent of deaths globally (80% in the developing world)”

1Big Pharma relies on profits from the sales of medicines for these diseasesBig Pharma says nations abuse the rights to issue compulsory licenses Especially middle-income nations with non-communicable diseases!

1

Global Classrooms, . Global Classrooms.

World Health Organization (WHO)

. Print. Slide3

Out of 57 million global deaths in 2008, 36 million (63%) were due to non-communicable diseases. Do you think this is a problem that the UN needs to tackle??

Many developed nations have strict patent protection laws. They say that diseases such as cancer and diabetes are less than an emergency than HIV/AIDs, malaria, and TB. What do you think??

Stop and think…Slide4

Generic Drug Market

79% of the world market relies on generic drugs80% of all generic AVRs (drugs to fight HIV/AIDs) are made in India!

Top generic drug companies:

Ratiopharm

(Germany)Teva Pharmaceutical Industries (Israel)Ranbaxy (India)In 2012, many AVR patents expired and many more will expire in 2014. What does this mean for Big

Pharma

??Slide5

“Tiered Pricing”

Country

GPD per capita (in USD)

Brand-Name

Drug PriceUSA

$47, 882

$100

Argentina

$10,

994

$65

Somalia

$907$20

Tiered Pricing allows developing nations to buy directly from Big

Pharma

companies at lower prices.

Tiered Pricing reduces the need for compulsory licenses.

How does this affect low-income countries (undeveloped)??

How does this affect middle-income countries (developing)??Slide6

“Patent Pooling”

UNITAID = UN initiative dealing with the purchase of medical drugsClinton Foundation + UNITAID = “Medical Patent Pool” program

Medical Patent Pool

Generic Drug for HIV/AIDs

Generic Drug for Malaria

Generic Drug for TB

http://www.youtube.com/watch?v=Vj0dbFgjoh4Slide7

Recent International Agreements

TRIPS Agreement in 199420-year patent period became the lawCompulsory patent licenses can be issued in times of severe emergencies

Doha Declaration in 2011

If one nation issues a compulsory license, other nations can simply buy the drugs from that nationSlide8

Up for Debate…

Is it fundamentally unfair for generic drugs to be produced at all? Is it right that smaller companies can make money of the R&D of large pharmaceutical companies? Does the fact that it makes lifesaving drugs more accessible make a difference?

Since lifesaving drugs are generally inaccessible to the world’s poor during the patent period, critics charge that major drug companies are simply profiting at the expense of the lives of the world’s poor. Given that patents make drugs less accessible, is it right to patent them at all?

Global Classrooms, . Global Classrooms.

World Health Organization (WHO). Print.